Rheumatoid arthritis

Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study

RMD OpenPublished Prospective longitudinal cohort study

Authors' conclusion

Persistent PDUS during follow-up, rather than at baseline, predicted worse outcome at 1 year

Study context

Population
Patients with rheumatoid arthritis (RA) (2010 ACR-EULAR criteria) in clinical remission (DAS28<2.6 without clinically active synovitis)
Participants
115 patients
Exposure
Persistent PDUS as predictor of relapse or radiographic progression
Outcome
Relapse or radiographic progression (≥1 point increase in mTSS)
Follow-up
1 year
Methodological detailsindependent ultrasonography investigator, US every 3 months for 1 year, univariate and multivariate Cox regression
  • Independent ultrasonography investigator
  • US every 3 months for 1 year
  • Univariate and multivariate Cox regression

Main finding

As reported in the abstract

Predictors of relapse/radiographic progression (multivariate)
Persistent PDUS, HR
2.98
Persistent PDUS, p
p=0.014
Increase in DAS28-CRP at visit before relapse, HR
4.36
Increase in DAS28-CRP at visit before relapse, p
p=0.004

Observational data: associations, not effects.

Further findings

PDUS detection over follow-up (of 115 patients) · baseline, months 3, 6, 9, 12

Baseline
75 (65.2%)
Month 3
66
Month 6
60
Month 9
46
Month 12
29
Persistent PDUS
58 (50.4%)

Relapse and radiographic progression · 1 year

Relapse
22/85 (25.9%)
Radiographic progression
12 (14.1%)

Original publication

Persistence of power Doppler ultrasonography-detected synovitis over 1 year of follow-up predicts poor prognosis in rheumatoid arthritis in clinical remission: the SONORE prospective longitudinal study. RMD Open. Published 17 September 2024. doi:10.1136/rmdopen-2024-004269

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.